New tracking tech aims to reduce radiation side effects for prostate cancer patients
NCT ID NCT03254420
Summary
This study is testing whether a newer, more precise radiation tracking system causes fewer long-term side effects in the pelvic area compared to standard radiation for prostate cancer. Men with low- or intermediate-risk prostate cancer will be randomly assigned to receive radiation using either the newer Calypso tracking system or the conventional method. The main goal is to see which technique results in fewer serious side effects like bowel or bladder problems in the years following treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut regional du Cancer - Val d Aurelle
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.